Drug Landscape ›
Ringer-lactate "SAD" ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 156
Most-reported reactions
Hypotension — 23 reports (14.74%) Vomiting — 20 reports (12.82%) Nausea — 17 reports (10.9%) Anaphylactic Shock — 15 reports (9.62%) Diarrhoea — 15 reports (9.62%) Drug Ineffective — 15 reports (9.62%) Pyrexia — 15 reports (9.62%) Off Label Use — 14 reports (8.97%) Anaesthetic Complication — 11 reports (7.05%) Cardiac Arrest — 11 reports (7.05%)
Source database →
Ringer-lactate "SAD" in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ringer-lactate "SAD" approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Ringer-lactate "SAD" in United States?
K. C. Rasmussen is the originator. The local marketing authorisation holder may differ — check the official source linked above.